Archive

With the Supreme Court closely tracking policy makers, both on the drug pricing and clinical trials front, will the pharmaceutical…

Brilinta is indicated to reduce heart attack and cardiovascular death in patients with Acute Coronary Syndromes

IDMA-GSB to conduct extraordinary EC meeting tomorrow

It is targeted that by 2015, the Indian pharma export will touch $25 billion

Software to be launched on November 1, 2012

Organisers are looking to identify, fund and nurture healthcare innovations in India

Event to be held in Mumbai on October 19, 2012

Lupin announced today that its subsidiary Lupin Pharmaceuticals has received final approval for its Irbesartan Tablets

Open publication - For Past Issues

In the DEBELLUM trial, 50 patients were randomly assigned to either conventional angioplasty or the DEB procedure